Key result
Hypertension affects ~30% of adults in Sub-Saharan Africa with substantial regional and urban-rural disparities.
Meta-Analysis (n=533,167)
Effect estimate: 29.9% (95% CI 27.8% - 32.1%)
Approximately one in three adults in Sub-Saharan Africa is estimated to have hypertension, highlighting a significant public health burden with substantial regional, urban-rural, and age-related disparities.
Highlights substantial hypertension burden requiring enhanced screening in Sub-Saharan Africa; extends inconsistent prior estimates with a region-wide meta-analysis.
Hypertension is a leading cause of cardiovascular disease and premature death in Sub-Saharan Africa (SSA), but region-wide prevalence estimates remain inconsistent due to fragmented evidence. To estimate the pooled prevalence of hypertension in SSA and examine regional, urban-rural, and age-related disparities. We searched PubMed, Scopus, Web of Science, African Journals Online, and Google Scholar for observational studies published between 2010 and 2025 reporting hypertension prevalence (systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg or antihypertensive medication use) among adults (≥ 18 years) in SSA. Two independent reviewers screened records, extracted data, and assessed quality using the Newcastle-Ottawa Scale. Random-effects meta-analysis using logit transformation was performed to pool prevalence. Heterogeneity was assessed using I², and publication bias was evaluated with funnel plots and Egger’s test. Subgroup analyses were conducted by region, urban/rural setting, age, and sex. Of 3,250 records, 45 studies (533,167 participants, 26 countries) met inclusion criteria for meta-analysis. The pooled hypertension prevalence was 29.9% (95% CI: 27.8% – 32.1%) using logit transformation, with similar estimates from arithmetic (30.5%) and geometric (30.1%) means. Prevalence was higher in urban (32.9%) than rural (26.3%) settings. Southern Africa had the highest prevalence (34.8%), followed by West Africa (31.2%), Central Africa (29.6%), and Eastern Africa (27.2%). Prevalence increased steeply with age, from 10.6% (21–30 years) to 66.4% (71–80 years). Heterogeneity was extreme (I² = 98.8%, p < 0.001). Egger’s test suggested publication bias ( p = 0.042). The majority of studies (71.1%) were high quality. Approximately one in three adults in Sub-Saharan Africa is estimated to have hypertension, with substantial regional and urban-rural disparities. The steep age gradient signals a potential window for early screening and prevention.
No takes yet. Share an insight, caveat, or question.
Eling et al. (2026) conducted a meta-analysis in Hypertension (n=533,167). Sub-Saharan Africa residence was evaluated on Pooled hypertension prevalence (29.9%, 95% CI 27.8% - 32.1%). The pooled prevalence of hypertension among adults in Sub-Saharan Africa is estimated to be 29.9%, with substantial regional and urban-rural disparities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: